0001179110-19-004244.txt : 20190325
0001179110-19-004244.hdr.sgml : 20190325
20190325201037
ACCESSION NUMBER: 0001179110-19-004244
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190322
FILED AS OF DATE: 20190325
DATE AS OF CHANGE: 20190325
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schueren Robert Alan
CENTRAL INDEX KEY: 0001597341
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37478
FILM NUMBER: 19703827
MAIL ADDRESS:
STREET 1: 7400 PASEO PADRE PARKWAY
CITY: FREMONT
STATE: CA
ZIP: 94555
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Natera, Inc.
CENTRAL INDEX KEY: 0001604821
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 010894487
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 201 INDUSTRIAL ROAD
STREET 2: SUITE 410
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
BUSINESS PHONE: 650-249-9090
MAIL ADDRESS:
STREET 1: 201 INDUSTRIAL ROAD
STREET 2: SUITE 410
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
4
1
edgar.xml
FORM 4 -
X0306
4
2019-03-22
0
0001604821
Natera, Inc.
NTRA
0001597341
Schueren Robert Alan
201 INDUSTRIAL ROAD
SUITE 410
SAN CARLOS
CA
94070
0
1
0
0
Chief Operating Officer
Restricted Stock Units
2019-03-22
4
A
0
100000
0
A
2029-03-21
Common Stock
100000
100000
D
Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the achievement of the Performance Vesting Conditions.
The RSU vests upon the Reporting Person achieving certain milestones relating to a combination of the passage of time and the Reporting Person achieving certain milestones relating to the Issuer's stock price, based on the average closing price per share of the Issuer's common stock for a calendar month, calculated as of the last day of such calendar month. The first milestone is the Issuer's stock price equaling or exceeding the quotient of (i) $2,000,000,000 and (ii) the Issuer's outstanding shares as most recently reported on the Issuer's Form 10-Q or Form 10-K (the "Capitalization"). The second milestone is the Issuer's stock price equaling or exceeding the quotient of (i) $3,000,000,000 and (ii) the Capitalization (the "Performance Vesting Conditions").
/s/ Tami Chen, attorney-in-fact
2019-03-25